As of 2025-09-19, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (3.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -1127.7%.
The range of the Relative Valuation is (2.43) - (3.64) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 10.3x | 8.6x |
| Forward P/E multiples | 6.8x - 10.3x | 8.6x |
| Fair Price | (2.43) - (3.64) | (3.03) |
| Upside | -922.2% - -1333.3% | -1127.7% |
| Date | P/E |